Financhill
Sell
21

SGHT Quote, Financials, Valuation and Earnings

Last price:
$3.52
Seasonality move :
7.01%
Day range:
$3.41 - $3.61
52-week range:
$2.03 - $9.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.28x
P/B ratio:
2.86x
Volume:
236.6K
Avg. volume:
390.4K
1-year change:
56.44%
Market cap:
$182.6M
Revenue:
$77.4M
EPS (TTM):
-$0.74

Analysts' Opinion

  • Consensus Rating
    Sight Sciences, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $8.50, Sight Sciences, Inc. has an estimated upside of 141.48% from its current price of $3.52.
  • Price Target Downside
    According to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $3.52.

Fair Value

  • According to the consensus of 5 analysts, Sight Sciences, Inc. has 141.48% upside to fair value with a price target of $8.50 per share.

SGHT vs. S&P 500

  • Over the past 5 trading days, Sight Sciences, Inc. has underperformed the S&P 500 by -14.86% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Sight Sciences, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Sight Sciences, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Sight Sciences, Inc. reported revenues of $20.4M.

Earnings Growth

  • Sight Sciences, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Sight Sciences, Inc. reported earnings per share of -$0.08.
Enterprise value:
138.9M
EV / Invested capital:
--
Price / LTM sales:
2.28x
EV / EBIT:
--
EV / Revenue:
1.80x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.64x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$66.7M
Return On Assets:
-30.69%
Net Income Margin (TTM):
-49.67%
Return On Equity:
-52.87%
Return On Invested Capital:
-33.93%
Operating Margin:
-18%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $81.1M $79.9M $77.4M $19.1M $20.4M
Gross Profit $69.2M $68.3M $66.7M $16.6M $17.8M
Operating Income -$57.3M -$50.5M -$37.1M -$11.9M -$3.7M
EBITDA -$56.1M -$50M -$36.6M -$11.8M -$3.6M
Diluted EPS -$1.14 -$1.03 -$0.74 -$0.23 -$0.08
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $277M $209.7M $162.9M $139.8M $112.7M
Total Assets $280.2M $213.1M $166.7M $142.8M $115.3M
Current Liabilities $13.5M $17.8M $12.3M $15.5M $11M
Total Liabilities $48.1M $53M $46.4M $55.3M $51.4M
Total Equity $232.1M $160.1M $120.2M $87.5M $63.9M
Total Debt $33.7M $33.9M $34.8M $39.8M $40.3M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations -$47.2M -$22.4M -$29.7M -$3.2M -$1.8M
Cash From Investing -$791K -$385K -$224K -$137K $156K
Cash From Financing $1.1M $5M $1.8M $5.2M $1.3M
Free Cash Flow -$48M -$22.7M -$29.9M -$3.4M -$1.7M
SGHT
Sector
Market Cap
$182.6M
$23.9M
Price % of 52-Week High
38.11%
47.44%
Dividend Yield
0%
0%
Shareholder Yield
-0.7%
-1.9%
1-Year Price Total Return
56.44%
-18.29%
Beta (5-Year)
--
0.513
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $3.80
200-day SMA
Sell
Level $5.11
Bollinger Bands (100)
Sell
Level 4.63 - 7.95
Chaikin Money Flow
Sell
Level -986.1K
20-day SMA
Sell
Level $3.76
Relative Strength Index (RSI14)
Sell
Level 35.42
ADX Line
Sell
Level 18.79
Williams %R
Buy
Level -84.2857
50-day SMA
Sell
Level $4.89
MACD (12, 26)
Buy
Level 0.97
25-day Aroon Oscillator
Sell
Level -56
On Balance Volume
Sell
Level -1.2M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.9522)
Sell
CA Score (Annual)
Level (-1.1275)
Buy
Beneish M-Score (Annual)
Level (-2.878)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (2.1837)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

Stock Forecast FAQ

In the current month, SGHT has received 3 Buy ratings 2 Hold ratings, and 0 Sell ratings. The SGHT average analyst price target in the past 3 months is $8.50.

  • Where Will Sight Sciences, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Sight Sciences, Inc. share price will rise to $8.50 per share over the next 12 months.

  • What Do Analysts Say About Sight Sciences, Inc.?

    Analysts are divided on their view about Sight Sciences, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sight Sciences, Inc. is a Sell and believe this share price will drop from its current level to $5.00.

  • What Is Sight Sciences, Inc.'s Price Target?

    The price target for Sight Sciences, Inc. over the next 1-year time period is forecast to be $8.50 according to 5 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is SGHT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Sight Sciences, Inc. is a Buy. 3 of 5 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of SGHT?

    You can purchase shares of Sight Sciences, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sight Sciences, Inc. shares.

  • What Is The Sight Sciences, Inc. Share Price Today?

    Sight Sciences, Inc. was last trading at $3.52 per share. This represents the most recent stock quote for Sight Sciences, Inc.. Yesterday, Sight Sciences, Inc. closed at $3.52 per share.

  • How To Buy Sight Sciences, Inc. Stock Online?

    In order to purchase Sight Sciences, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
46
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 36x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 27x

Alerts

Buy
51
AAOI alert for Apr 3

Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.

Buy
59
SBAC alert for Apr 3

SBA Communications Corp. [SBAC] is up 18.96% over the past day.

Buy
55
VSAT alert for Apr 3

ViaSat, Inc. [VSAT] is up 18.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock